{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:15:35Z","timestamp":1790453735210,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.neuro.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T02:32:05Z","timestamp":1375410725000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls"],"prefix":"10.1016","volume":"38","author":[{"given":"Elan D.","family":"Louis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Factor-Litvak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul G.","family":"Vonsattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Galecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2013.07.002_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuropharm.2005.08.022","article-title":"In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain","volume":"50","author":"Anderson","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mds.10376","article-title":"Prevalence of essential tremor in three elderly populations of central Spain","volume":"18","author":"Benito-Leon","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2013.07.002_bib0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ncpneuro0347","article-title":"Essential tremor: emerging views of a common disorder","volume":"2","author":"Benito-Leon","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.neuro.2013.07.002_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2013.07.002_bib0025","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0197-4580(97)00062-6","article-title":"Diagnostic criteria for neuropathologic assessment of Alzheimer's disease","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2013.07.002_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-1110(95)90008-X","article-title":"Genotoxic potential of beta-carbolines: a review","volume":"339","author":"De Meester","year":"1995","journal-title":"Mutat Res"},{"key":"10.1016\/j.neuro.2013.07.002_bib0035","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1289\/ehp.10352","article-title":"Elevated blood lead concentrations in essential tremor: a case-control study in Mersin, Turkey","volume":"115","author":"Dogu","year":"2007","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuro.2013.07.002_bib0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2377-7-24","article-title":"High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians","volume":"7","author":"Fabrizio","year":"2007","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neuro.2013.07.002_bib0045","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/0024-3205(93)90689-Z","article-title":"Occurrence and partition of the beta-carboline norharman in rat organs","volume":"52","author":"Fekkes","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.neuro.2013.07.002_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0028-3908(71)90004-9","article-title":"An investigation on the central effects of harmine, harmaline and related beta-carbolines","volume":"10","author":"Fuentes","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1530-0277.2001.tb02203.x","article-title":"Identification of heavy drinkers by using the early detection of alcohol consumption score","volume":"25","author":"Harasymiw","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.neuro.2013.07.002_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0006-8993(70)90481-6","article-title":"[3H]harmaline distribution in monkey brain; pharmacological and autoradiographic study","volume":"22","author":"Ho","year":"1970","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2013.07.002_bib0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000103646","article-title":"Environmental risk factors for essential tremor","volume":"58","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2007","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neuro.2013.07.002_bib0070","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/BF01271257","article-title":"Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients","volume":"103","author":"Kuhn","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuro.2013.07.002_bib0075","first-page":"49","article-title":"MPTP-induced parkinsonism in human and non-human primates\u2014clinical and experimental aspects","volume":"100","author":"Langston","year":"1984","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.neuro.2013.07.002_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01864238","article-title":"Untersuchungen Uber Banisteria caapi","volume":"129","author":"Lewin","year":"1928","journal-title":"Sp Arch Exp Pathol Pharmacol"},{"key":"10.1016\/j.neuro.2013.07.002_bib0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(10)70090-9","article-title":"Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem enquiry","volume":"9","author":"Louis","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuro.2013.07.002_bib0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jnnp.2010.215681","article-title":"Rest tremor in advanced essential tremor: a post-mortem study of nine cases","volume":"82","author":"Louis","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuro.2013.07.002_bib0095","doi-asserted-by":"crossref","DOI":"10.1002\/mds.25400","article-title":"The inferior olivary nucleus: a postmortem study of essential tremor cases versus controls","author":"Louis","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2013.07.002_bib0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuro.2012.09.004","article-title":"Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain","volume":"34","author":"Louis","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0105","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mds.20583","article-title":"Essential tremor centralized brain repository: diagnostic validity and clinical characteristics of a highly selected group of essential tremor cases","volume":"20","author":"Louis","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2013.07.002_bib0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.neuro.2006.03.005","article-title":"Organochlorine pesticide exposure in essential tremor: a case-control study using biological and occupational exposure assessments","volume":"27","author":"Louis","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0115","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/brain\/awm266","article-title":"Neuropathological changes in essential tremor: 33 cases compared with 21 controls","volume":"130","author":"Louis","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2013.07.002_bib0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/15287394.2012.688485","article-title":"Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York","volume":"75","author":"Louis","year":"2012","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.neuro.2013.07.002_bib0125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuro.2007.12.001","article-title":"Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor","volume":"29","author":"Louis","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0130","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/01.wnl.0000218162.80315.b9","article-title":"Neuropathologic findings in essential tremor","volume":"66","author":"Louis","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/01.wnl.0000172352.88359.2d","article-title":"Blood harmane concentrations and dietary protein consumption in essential tremor","volume":"65","author":"Louis","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0140","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1212\/01.WNL.0000038385.60538.19","article-title":"Elevation of blood beta-carboline alkaloids in essential tremor","volume":"59","author":"Louis","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2013.07.002_bib0145","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.20940","article-title":"Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor","volume":"21","author":"Martin","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuro.2013.07.002_bib0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0006-8993(93)91221-D","article-title":"Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions are present in human brain","volume":"610","author":"Matsubara","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2013.07.002_bib0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0166-4328(96)00079-4","article-title":"Plant hallucinogens: springboards for psychotherapeutic drug discovery","volume":"73","author":"McKenna","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuro.2013.07.002_bib0160","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0197-4580(97)00058-4","article-title":"The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary","volume":"18","author":"Mirra","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2013.07.002_bib0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0378-4347(00)82576-1","article-title":"Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection","volume":"496","author":"Moncrieff","year":"1989","journal-title":"J Chromatogr"},{"key":"10.1016\/j.neuro.2013.07.002_bib0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchromb.2003.10.044","article-title":"Exposure to beta-carbolines norharman and harman","volume":"802","author":"Pfau","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.neuro.2013.07.002_bib0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jns.2006.09.007","article-title":"Exploring the relationship between caffeine intake and essential tremor","volume":"251","author":"Prakash","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2013.07.002_bib0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1248\/yakushi1947.115.5_351","article-title":"Chemical studies of indole alkaloids","volume":"115","author":"Sakai","year":"1995","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.neuro.2013.07.002_bib0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00713856","article-title":"Population-based case-control study of essential tremor","volume":"19","author":"Salemi","year":"1998","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.neuro.2013.07.002_bib0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuro.2013.07.002_bib0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000136294","article-title":"Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids","volume":"7","author":"Zetler","year":"1972","journal-title":"Pharmacology"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X13001162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X13001162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T07:23:18Z","timestamp":1563607398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X13001162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"alternative-id":["S0161813X13001162"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2013.07.002","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}